Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr

What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Operating Activities ratio of NATCO PHARMA is ₹1,697 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹1,697 Cr
Mar2024₹1,212 Cr
Mar2023₹849 Cr
Mar2022₹47 Cr
Mar2021₹299 Cr

How is Cash Flow from Operating Activities of NATCO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹1,697 Cr
40.05
Mar2024 ₹1,212 Cr
42.69
Mar2023 ₹849 Cr
1,726.02
Mar2022 ₹47 Cr
-84.44
Mar2021 ₹299 Cr -

Compare Cash Flow from Operating Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,929.8 Cr 3% -5.7% -40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,140.0 Cr 2.1% 2.4% -11.5% Stock Analytics
DIVIS LABORATORIES ₹175,290.0 Cr 0.7% 8.2% 8.1% Stock Analytics
CIPLA ₹132,417.0 Cr 5.6% 3.9% 1% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,839.0 Cr 1.5% 0.1% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,031.0 Cr 3.7% -3% -6.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

3%

-5.7%

-40.9%

SENSEX

2.5%

2%

3.1%


You may also like the below Video Courses